We are live on ! Find out more
EDIT icon

Editas Medicine
EDIT

206 hedge funds and large institutions have $64.8M invested in Editas Medicine in 2024 Q4 according to their latest regulatory filings, with 39 funds opening new positions, 61 increasing their positions, 57 reducing their positions, and 58 closing their positions.

New
Increased
Maintained
Reduced
Closed

7% more repeat investments, than reductions

Existing positions increased: 61 | Existing positions reduced: 57

2% more call options, than puts

Call options by funds: $396K | Put options by funds: $388K

5.01% less ownership

Funds ownership: 66.86% → 61.84% (-5%)

10% less funds holding

Funds holding: 229 → 206 (-23)

33% less first-time investments, than exits

New positions opened: 39 | Existing positions closed: 58

65% less capital invested

Capital invested by funds: $188M → $64.8M (-$123M)

Holders
206
Holders Change
-23
Holders Change %
-10.04%
% of All Funds
2.71%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
39
Increased
61
Reduced
57
Closed
58
Calls
$396K
Puts
$388K
Net Calls
+$8K
Net Calls Change
-$354K

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$3.7M
2
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$2.87M
3
MAM
Monaco Asset Management
Monaco
+$2.73M
4
UBS Group
UBS Group
Switzerland
+$1.79M
5
AQR Capital Management
AQR Capital Management
Connecticut
+$1.77M

Top Sellers

Rank Fund Capital Flow
1
DTC
Deep Track Capital
Connecticut
-$16.7M
2
APM
Avidity Partners Management
Texas
-$5M
3
Pictet Asset Management
Pictet Asset Management
Switzerland
-$4.02M
4
BlackRock
BlackRock
New York
-$1.83M
5
Millennium Management
Millennium Management
New York
-$1.54M
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of America
26
Bank of America
North Carolina
$550K -$1.14M -449,067 -51%
TCM
27
Tang Capital Management
California
$508K +$1.02M +400,000 New
Stifel Financial
28
Stifel Financial
Missouri
$428K -$733K -287,718 -46%
N
29
Nuveen
North Carolina
$402K +$154K +60,583 +24%
SFI
30
Susquehanna Fundamental Investments
Pennsylvania
$346K +$694K +272,430 New
HWAM
31
Hennion & Walsh Asset Management
New Jersey
$340K +$104K +41,002 +18%
Bank of New York Mellon
32
Bank of New York Mellon
New York
$309K +$1.18K +463 +0.2%
Raymond James Financial
33
Raymond James Financial
Florida
$303K +$609K +238,967 New
Ameriprise
34
Ameriprise
Minnesota
$289K +$428K +168,134 +283%
Fidelity Investments
35
Fidelity Investments
Massachusetts
$287K +$57.5K +22,570 +11%
Prudential Financial
36
Prudential Financial
New Jersey
$250K +$131K +51,600 +35%
Acadian Asset Management
37
Acadian Asset Management
Massachusetts
$244K +$493K +193,595 New
Squarepoint
38
Squarepoint
New York
$241K +$247K +96,749 +104%
Wells Fargo
39
Wells Fargo
California
$237K -$811K -318,436 -63%
Barclays
40
Barclays
United Kingdom
$230K +$6.96K +2,731 +2%
D.E. Shaw & Co
41
D.E. Shaw & Co
New York
$228K -$13.3K -5,200 -3%
Mirae Asset Global ETFs Holdings
42
Mirae Asset Global ETFs Holdings
Hong Kong
$224K +$12.1K +4,736 +3%
BCM
43
Bridgeway Capital Management
Texas
$191K +$382K +150,000 New
BNP Paribas Financial Markets
44
BNP Paribas Financial Markets
France
$183K +$227K +89,273 +163%
RhumbLine Advisers
45
RhumbLine Advisers
Massachusetts
$179K -$2.95K -1,158 -0.8%
AllianceBernstein
46
AllianceBernstein
Tennessee
$170K -$3.06K -1,200 -0.9%
AC
47
Aristides Capital
Kentucky
$168K +$336K +131,900 New
Ohio Public Employees Retirement System (OPERS)
48
Ohio Public Employees Retirement System (OPERS)
Ohio
$142K +$200K +78,513 +236%
GAA
49
Green Alpha Advisors
Colorado
$142K +$174K +68,295 +158%
XT
50
XTX Topco
Cayman Islands
$133K +$134K +52,498 +100%
1
2
3 4 5

EDIT Hedge Fund Activity: Q4 2024 in Review

206 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Editas Medicine (EDIT) for Q4 2024, worth a combined $64.8M — down 65% from $188M a quarter earlier.

Sellers outnumbered buyers: 58 funds closed out of EDIT and 39 opened new positions — a net loss of 19 holders — while 57 trimmed existing stakes and 61 added.

The largest buyer was Renaissance Technologies, opening a new position worth an estimated $3.7M. The largest seller was Deep Track Capital, exiting entirely with an estimated $16.7M sold.

  • 206 institutional investors held Editas Medicine (EDIT) as of Q4 2024, down from 229 in Q3 2024.
  • Funds reported $64.8M of Editas Medicine stock for Q4 2024, down 65% quarter-over-quarter.
  • 39 funds opened new Editas Medicine positions in Q4 2024 and 58 closed out, a net change of -19 holders.
  • The largest Editas Medicine buyer in Q4 2024 was Renaissance Technologies, an estimated $3.7M added.
  • The largest Editas Medicine seller in Q4 2024 was Deep Track Capital, an estimated $16.7M sold.

Based on aggregated 13F filings for Q4 2024.